Abstract
Gastro-oesophageal reflux disease (GERD), in layman’s terms known as heartburn, is a condition characterised by frequent oesophageal contact with gastric acid. Contrary to what is generally accepted, GERD is not caused by excessive quantities of gastric acid. Rather, symptoms result from any combination of a number of contributing factors, including decreased lower oesophageal sphincter pressure, hiatus hernia (where the stomach protrudes through the diaphragm), reduced oesophageal and gastric clearance and compromised oesophageal mucosa barrier integrity. Although most patients are able to manage GERD symptoms by means of lifestyle changes, chronic and recurrent episodes of reflux may result in erosive oesophagitis, nasal inflammation, dysphagia, i.e. difficulty in swallowing, and even pulmonary complications, e.g. asthma.
Reference45 articles.
1. Williams DB, Schade RR. Gastroesophageal reflux disease. In: Linn WD, Wofford MR, O’Keefe ME, Posey LM. Pharmacotherapy in Primary Care. New York: McGraw-Hill Medical; 2009: p. 135.
2. Kahrilas PJ, Shaheen NJ, Vaezi MF. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135(4):1383-1391.e5. https://doi.org/10.1053/j.gastro.2008.08.045.
3. Pandolfino JE, El-Serag HB, Zhang Q, et al. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006;130(3):639-649. https://doi.org/10.1053/j.gastro.2005.12.016.
4. Lowe RC. Medical management of gastroesophageal reflux disease. GI Motility online. 2006.
5. Hrelja N, Zerem E. Proton pump inhibitors in the management of gastroesophageal reflux disease. Medical Archives. 2011;65(1):52.